These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 1413068

  • 1. Immunosuppression by aminopterin or idarubicin conjugated to anti-CD8 in the mouse heart allograft model.
    Mottram PL, Pietersz GA, Purcell LJ, Krauer K, McKenzie IF.
    Transplant Proc; 1992 Oct; 24(5):2301. PubMed ID: 1413068
    [No Abstract] [Full Text] [Related]

  • 2. Immunosuppression by anti-CD8 (Ly-2.1) MAb conjugated to idarubicin: studies in the mouse heart graft model.
    Mottram PL, Pietersz GA, Purcell LJ, Clunie GJ, McKenzie IF.
    Transplant Proc; 1990 Oct; 22(5):2111-2. PubMed ID: 2120812
    [No Abstract] [Full Text] [Related]

  • 3. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
    Chen Z, Cobbold S, Waldmann H, Metcalfe S.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
    [No Abstract] [Full Text] [Related]

  • 4. Tolerance induction with anti-CD8 monoclonal antibodies in the mouse heart transplant model.
    Mottram PL, Purcell LJ, Pietersz GA, McKenzie IF.
    Transplant Proc; 1993 Oct; 25(5):2935-6. PubMed ID: 8212289
    [No Abstract] [Full Text] [Related]

  • 5. Tolerance induction in concordant heart-xenografted mice by CD4 and CD8 monoclonal antibodies.
    Chen Z, Cobbold SP, Waldmann H, Metcalfe SM.
    Transplant Proc; 1994 Jun; 26(3):1199-200. PubMed ID: 8029885
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice.
    Lowry RP, Konieczny B, Alexander D, Larsen C, Pearson T, Smith S, Narula S.
    Transplant Proc; 1995 Feb; 27(1):392-4. PubMed ID: 7879034
    [No Abstract] [Full Text] [Related]

  • 7. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
    Isobe M, Suzuki J, Yagita H, Okumura K, Sekiguchi M.
    Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
    [No Abstract] [Full Text] [Related]

  • 8. Anti-T cell monoclonal antibodies for in vivo treatment of cardiac allograft rejection in mice.
    Mottram PL, Smyth M, Pietersz GA, Clunie GJ, McKenzie IF.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1020-1. PubMed ID: 2650063
    [No Abstract] [Full Text] [Related]

  • 9. Deletion of graft reactive cells by idarubicin-anti-CD8 (Ly-2.1) immunoconjugate: studies in the mouse heart graft model.
    Mottram PL, Pietersz GA, Purcell LJ, Krauer K, Clunie GJ, McKenzie IF.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):499-500. PubMed ID: 1899311
    [No Abstract] [Full Text] [Related]

  • 10. Intrathymic tolerance induction is based on suppressor cells.
    Kampinga J, Klatter F, Bartels H, Pater J, Nieuwenhuis P, Roser B, Groen H.
    Transplant Proc; 1994 Apr; 26(2):725-6. PubMed ID: 8171626
    [No Abstract] [Full Text] [Related]

  • 11. Prolonged survival of mouse cardiac allografts after CD4 or CD8 monoclonal antibody therapy is associated with selective intragraft cytokine protein expression: interleukin (IL)-4 and IL-10 but not IL-2 or interferon-gamma.
    Hancock W, Mottram PL, Purcell LJ, Han WR, Pietersz GA, McKenzie IF.
    Transplant Proc; 1993 Oct; 25(5):2937-8. PubMed ID: 8212290
    [No Abstract] [Full Text] [Related]

  • 12. Microchimerism and graft acceptance: IV. Cardiac allograft acceptance following anti-adhesion molecule antibody therapy.
    Suzuki H, Hara MH, Miyahara T, Tanigawa M, Matsuzaki Y, Onitsuka T, Shibata K, Koga Y, Yamashita A, Miyamoto M, Suzuki S, Amemiya H, Iwaya M, Miyasaka M, Kimura H.
    Transplant Proc; 1996 Aug; 28(4):2058-60. PubMed ID: 8769155
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of CD4 depleting and nondepleting monoclonal antibodies in the mouse heart allograft model.
    Han WR, Mottram PL, McKenzie IF.
    Transplant Proc; 1993 Oct; 25(5):2933-4. PubMed ID: 8105591
    [No Abstract] [Full Text] [Related]

  • 14. Prolongation of fetal pancreas allograft survival in mice treated with anti-IL-2 receptor monoclonal antibody (PC61) conjugated with idarubicin.
    Koulmanda M, Pietersz G, McKenzie IF, Mandel TE.
    Transplant Proc; 1990 Oct; 22(5):2113-4. PubMed ID: 2219312
    [No Abstract] [Full Text] [Related]

  • 15. Microchimerism and graft acceptance: cardiac allograft acceptance following antiadhesion molecules antibody therapy.
    Hara MH, Tanigawa M, Matsuzaki M, Onitsuka T, Shibata K, Koga Y, Suzuki H, Yamashita A, Miyamoto M, Li XK, Suzuki S, Amemiya H, Yokoi Y, Iwaya M, Yamaguchi A, Masaki Y, Miyasaka M, Kimura H.
    Transplant Proc; 1996 Jun; 28(3):1370-1. PubMed ID: 8658699
    [No Abstract] [Full Text] [Related]

  • 16. Effects of anti-L3T4 and anti-LYT2 monoclonal antibody therapy on cardiac allograft survival in presensitized recipients.
    Madsen JC, Wood KJ, Morris PJ.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1022. PubMed ID: 2495588
    [No Abstract] [Full Text] [Related]

  • 17. Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts.
    Hamano K, Rawsthorne M, Bushell A, Morris PJ, Wood KJ.
    Transplant Proc; 1995 Feb; 27(1):151-2. PubMed ID: 7878951
    [No Abstract] [Full Text] [Related]

  • 18. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
    Wang J, Zhang L, Tang J, Jiang S, Wang X.
    Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
    [Abstract] [Full Text] [Related]

  • 19. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
    Hamano K, Morris PJ, Wood KJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
    [No Abstract] [Full Text] [Related]

  • 20. LFA-1 and ICAM-1 antibody-idarubicin conjugates separately prolong murine cardiac allograft survival.
    Pietersz GA, Sandrin MS, Ling S, Li YQ, McKenzie IFC.
    Transpl Immunol; 2001 Oct; 9(1):7-11. PubMed ID: 11680574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.